Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
My American Story
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
My American Story
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Gilead Sciences
(NQ:
GILD
)
153.28
+0.61 (+0.40%)
Streaming Delayed Price
Updated: 10:03 AM EDT, Sep 23, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
794,537
Open
153.60
Bid (Size)
153.15 (100)
Ask (Size)
153.41 (500)
Prev. Close
152.67
Today's Range
152.50 - 154.20
52wk Range
108.46 - 157.29
Shares Outstanding
1,253,809,440
Dividend Yield
2.14%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Better Healthcare ETF: Invesco's Biotech-Focused IBBQ vs. iShares' Broad IYH
↗
September 22, 2026
IBBQ offers concentrated biotech exposure with lower costs and stronger recent returns, while IYH provides broader sector diversification and higher dividend income.
Via
The Motley Fool
Topics
ETFs
1 Cash-Producing Stock on Our Buy List and 2 We Find Risky
September 22, 2026
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
Via
StockStory
Performance
YTD
+26.1%
+26.1%
1 Month
+4.5%
+4.5%
3 Month
+22.6%
+22.6%
6 Month
+11.0%
+11.0%
1 Year
+36.3%
+36.3%
More News
Read More
Lakefront Biotherapeutics Targets 2027 Registrational Trials for Gamgertamig
↗
September 21, 2026
Via
MarketBeat
Gilead Sciences (NASDAQ:GILD): A Quality Dividend Stock for Income Investors
↗
September 04, 2026
Via
Chartmill
What's going on in today's after hours session: S&P500 movers
↗
August 27, 2026
Via
Chartmill
Gilead Accelerates Global Access Planning for Investigational Once-Yearly Lenacapavir for HIV Prevention
September 16, 2026
From
Gilead Sciences, Inc.
Via
Business Wire
Gilead Sciences Sees Yeztugo Powering HIV Growth as Oncology Pipeline Advances
↗
September 15, 2026
Via
MarketBeat
Topics
Intellectual Property
PBE vs. RSPH: Is a Biotech ETF or Equal-Weight Healthcare ETF the Better Choice for Investors?
↗
September 15, 2026
Via
The Motley Fool
Topics
ETFs
Gilead and PAHO Announce Milestone Partnership to Accelerate Access to Twice-Yearly Lenacapavir for HIV Prevention Across Latin America and the Caribbean
September 15, 2026
From
Gilead Sciences, Inc.
Via
Business Wire
A $57 Billion Antiviral Market Is Taking Shape As The World Prepares For The Next Viral Threat
September 15, 2026
Via
FinancialNewsMedia
A $57 Billion Antiviral Market Is Taking Shape As The World Prepares For The Next Viral Threat
September 15, 2026
From
MarketNewsUpdates.com
Via
GlobeNewswire
If You Invested $100 In Gilead Sciences Stock 20 Years Ago, You Would Have This Much Today
↗
September 10, 2026
Via
Benzinga
Gilead Sciences Sees Sunlenca Launch Fueling Long-Term HIV Growth
↗
September 10, 2026
Via
MarketBeat
Gilead Sciences Eyes HIV, Oncology Catalysts as Pipeline Enters Execution Mode
↗
September 10, 2026
Via
MarketBeat
1 S&P 500 Stock on Our Buy List and 2 Facing Challenges
September 09, 2026
Via
StockStory
Topics
Stocks
Gilead Opens State-of-the-Art Research Center to Advance the Next Generation of Medicines
September 08, 2026
From
Gilead Sciences, Inc.
Via
Business Wire
Gilead Sciences Just Won Its Third FDA Approval in Less Than 4 Months. Is the Stock Still Underrating This Turnaround Play?
↗
September 05, 2026
Via
The Motley Fool
Healthcare ETF Comparison: Fidelity's FHLC vs. Invesco's Biotech-Focused IBBQ
↗
September 02, 2026
Via
The Motley Fool
Topics
ETFs
FDA Approves Gilead's New Single Tablet HIV Regimen
↗
August 31, 2026
Via
Benzinga
3 Unpopular Stocks with Open Questions
August 31, 2026
Via
StockStory
Which Healthcare ETF Offers the Better Growth Outlook: VanEck Biotech or Invesco Pharmaceuticals?
↗
August 28, 2026
Via
The Motley Fool
Topics
ETFs
U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults With HIV, Including Those on Complex Regimens
August 27, 2026
From
Gilead Sciences, Inc.
Via
Business Wire
Gilead Sciences to Present at Upcoming Third Quarter 2026 Investor Conferences
August 26, 2026
From
Gilead Sciences, Inc.
Via
Business Wire
Gilead Sciences Has Snapped Out of Its Slump -- and 1 Catalyst Is Doing Most of the Heavy Lifting
↗
August 26, 2026
Via
The Motley Fool
3 Dividend Stocks to Hold for the Next 10 Years
↗
August 25, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Intellectual Property
Frequently Asked Questions
Is Gilead Sciences publicly traded?
Yes, Gilead Sciences is publicly traded.
What exchange does Gilead Sciences trade on?
Gilead Sciences trades on the Nasdaq Stock Market
What is the ticker symbol for Gilead Sciences?
The ticker symbol for Gilead Sciences is GILD on the Nasdaq Stock Market
What is the current price of Gilead Sciences?
The current price of Gilead Sciences is 153.28
When was Gilead Sciences last traded?
The last trade of Gilead Sciences was at 09/23/26 10:03 AM ET
What is the market capitalization of Gilead Sciences?
The market capitalization of Gilead Sciences is 192.18B
How many shares of Gilead Sciences are outstanding?
Gilead Sciences has 192B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at
/week.
Subscribe Today